Although no significant difference in the total serum IgE level before and after omalizumab administration was noted in all patients with ABPA, the total serum IgE level seemed to decrease obviously in patients with ABPA without AR. The gene discussed is IGHE; the disease is allergic bronchopulmonary aspergillosis.